|
Report Date : |
14.04.2012 |
IDENTIFICATION DETAILS
|
Name : |
UCI FARMA INDÚSTRIA
FARMACÊUTICA LTDA |
|
|
|
|
Registered Office : |
Rua Do
Cruzeiro,374 - |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.12.2008 |
|
|
|
|
Date of Incorporation : |
10.01.1978 |
|
|
|
|
Legal Form : |
Limited Liability Company |
|
|
|
|
Line of Business : |
Manufacture of Allopathic Medicines for Human Use |
|
|
|
|
No. of Employees : |
348 |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Maximum Credit Limit : |
USD 300.000,00 |
|
Status : |
Moderate |
|
Payment Behaviour : |
Unknown |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com while quoting report
number, name and date.
ECGC Country Risk Classification List – September 30, 2011
|
Country Name |
Previous Rating (31.12.2011) |
Current Rating (31.03.2012) |
|
Brazil |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
UCI FARMA INDÚSTRIA FARMACÊUTICA
LTDA
|
MAIN
ADDRESS: |
RUA DO CRUZEIRO,374 - VILA DUZZI |
|
ZIP CODE/CITY: |
09725-310 - SÃO BERNARDO DO CAMPO/SP |
|
|
|
|
PHONE: |
11 3165-7511 |
|
FAX: |
11 4125-5253 |
|
E-MAIL: |
pramuvi@uci-farma.com.br |
|
WEB SITE: |
www.uci-farma.com.br |
|
BRANCHES: |
|
|
|
|
|
ADDRESS: |
AVENIDA BRIGADEIRO FARIA LIMA,3311 12º ANDAR - ITAIM BIBI |
|
ZIP CODE/CITY: |
04538-113 SÃO PAULO/SP |
|
PHONE: |
11 3165-7511 |
|
FAX: |
11 3165-7511 |
|
MAIN
ACTIVITIES: |
|
MANUFACTURE OF ALLOPATHIC MEDICINES FOR HUMAN USE. |
|
LEGAL
FORM: |
LIMITED LIABILITY COMPANY |
|
|
|
|
INCORPORATION DATE: |
10/01/1978 |
|
REGISTER DATE: |
10/01/1978 |
|
BALANCE SHEET FILING DATE: |
31/12 |
|
TAX CONTRIBUTOR NUMBER(CNPJ): |
48.396.378/0001-82 |
|
STATE REGISTER: |
635.269.800.113 |
|
|
|
|
SHARE CAPITAL: |
R$
370.000,00 |
|
LAST REGISTER OF CAPITAL: |
21/03/1994 |
|
BOARD
OF DIRECTORS: |
|
|
|
|
|
ELIZIO VEIGA GIRALDEZ |
MANAGING PARTNER |
|
THE MANAGING PARTNER IS AUTHORIZED TO SIGN ON BEHALF OF
THE COMPANY. |
|
SHAREHOLDERS
/ PARTNERS: |
|
|
|
|
|
ELIZIO VEIGA GIRALDEZ |
R$
92.500,00 |
|
OTHERS |
R$
231.500,00 |
|
AIRTON RITONDARO SANCHEZ |
R$
46.000,00 |
|
AFFILIATES
/ SUBSIDIARIES: |
|
|
|
|
|
PERCHINA PRODUTOS QUÍMICOS LTDA |
100,00% |
|
BEMASC EMPREENDIMENTOS E PARTICIPAÇÕES LTDA. |
|
|
MIZRAIM PARTICIPAÇÕES LTDA. |
|
|
BAURU - ALPHA PRESTACAO DE SERVICOS ADMINISTRATIVOS LTDA |
|
|
GRIGA CONSTRUÇÕES E COMERCIO LTDA. |
|
|
USAFARMA PRODUTOS FARMACEUTICOS LTDA. |
|
|
PROMASA LABORATORIOS LTDA. |
|
|
PRECIFARMA LABORATORIO FARMACEUTICO LTDA. |
|
|
THE SUBJECT WAS ESTABLISHED IN 1978 AS LUCI - FARMA
INDUSTRIA DE PRODUTOS FARMACÊUTICOS LTDA. TO BE ENGAGED IN THE SAID LINE OF
BUSINESS. ON JANUARY 20, 1983 THE SUBJECT ADOPTED THE ABOVE MENTIONED NAME. THE COMPANY OPERATES WITH THE TRADE NAME: UCI - FARMA. PARTNERS: ELIZIO VEIGA GIRALDEZ: BRAZILIAN, HOLDER OF DOCUMENTS CPF
45.879.447-15, RG 2651455, RESEDENTIAL ADDRESS AT AV. CHIBARAS 415, APTO 71
SÃO PAULO/SP. AIRTON RITONDARO SANCHEZ: BRAZILIAN, HOLDER OF DOCUMENTS
CPF 22.642.018-35, RG 108.692528, RESEDENTIAL ADDRESS AT RUA MATHIAS JOSE
BINS 916, APTO 404, PORTO ALEGRE/RS. ACCORDING TO MR. OSLVADO AND ANDREA, THERE IS A PROCEEDING
UNDERGOING SINCE 2005, WHICH MAIN PURPOSE IS THE WITHDRAWAL OF THE PARTNERS
OSVALDO MENDES CAETANO, PIETRO BENEDETTO MASCARO AND DIVA RITONDARO SANCHEZ
FROM THE COMPANY'S BOARD. SUCH PROCEEDING IS STILL WAITING FOR THE JUDGE'S
DECISION, THUS AT THE REGISTER OF COMPANIES THE SUBJECT'S PARTNERS ARE THOSE
METIONED ABOVE. HOWEVER, UPON THE DECISION OF THE JUDGE, ACORDING TO THESES
SOURCES AT THE COMPANY THE PARTNERSHIP WILL BE COMPRISED BY ONLY TWO PARTNERS
WHICH ARE ELIZIO VEIGA GIRALDEZ AND AIRTON RITONDARO SANCHEZ, WHICH ARE THE
SUBJECT'S CURRENT ADMINSTRATORS. FURTHER DETAILS ARE SO FAR NOT KNOWN. REMARKS: -------- WHEN INTERVIEWED SOURCES AT THE SUBJECT STATED THAT ARE
STILL WAITING FOR AUTHORIZATION FROM THE PRINCIPALS TO PROVIDE THE DATA
NECESSARY TO COMPLETE THIS REPORT. A REQUEST FOR FURTHER DATA HAS BEEN SENT TO THE COMPANY.
PROVIDED THE DATA REQUESTED ARE RECEIVED FROM THE SUBJECT A COMPLEMENTARY
REPORT WILL BE SENT TO YOUR ATTENTION. THE DATA CONTAINED HEREIN WERE OBTAINED FROM OUTSIDE
SOURCES, OUR DATABASE AND OFFICIAL. NO FURTHER DATA WAS AVAILABLE WITH
SEVERAL SOURCES USUALLY INVESTIGATED. |
|
PUBLIC
RECORDS INFORMATION: |
|
NO DETRIMENTAL FILES WERE FOUND. |
|
GENERAL BALANCE SHEETS AS OF 31/12/2008. |
|
( FIGURES ARE IN REAIS ). |
|
ASSETS
|
|
|
|
|
CURRENT: |
31/12/2008 |
|
|
|
|
|
|
|
|
CASH |
1.659.449,65 |
|
|
|
CLIENTS |
6.442.826,53 |
|
|
|
INVENTORY |
7.342.200,98 |
|
|
|
OTHER CREDITS |
43.162,87 |
|
|
|
ADVANCES |
574.655,54 |
|
|
|
RECOVERABLE TAXES |
1.097.974,07 |
|
|
|
|
---------------- |
|
|
|
TOTAL CURRENT ASSETS |
17.160.269,64 |
|
|
|
FIXED
ASSETS: |
|
|
|
|
|
|
|
|
|
FIXED ASSETS |
1.412.256,51 |
|
|
|
INTANGIBLE |
16.893.342,04 |
|
|
|
|
---------------- |
|
|
|
TOTAL FIXED ASSETS |
18.305.598,55 |
|
|
|
|
================ |
|
|
|
TOTAL ASSETS |
35.465.868,19 |
|
|
|
LIABILITIES: |
|
|
|
|
CURRENT:
|
31/12/2008 |
|
|
|
|
|
|
|
|
SUPPLIERS |
1.699.776,11 |
|
|
|
ACCOUNTS PAYABLE |
5.723.526,05 |
|
|
|
TAXES & CONTRIBUTIONS |
1.052.504,58 |
|
|
|
SOCIAL OBLIGATIONS |
452.481,56 |
|
|
|
PROVISIONS/INCOME TAX |
92.226,99 |
|
|
|
|
---------------- |
|
|
|
TOTAL CURRENT LIABILITIES |
9.020.515,29 |
|
|
|
NET
EQUITY: |
|
|
|
|
|
|
|
|
|
SHARE CAPITAL |
370.000,00 |
|
|
|
CAPITAL RESERVES |
325.938,93 |
|
|
|
RESERVES |
113.622,36 |
|
|
|
REVALUATION RESERVES |
14.904.483,33 |
|
|
|
ACCRUED PROFIT (LOSS) |
12.241.308,28 |
|
|
|
OTHER |
-1.510.000,00 |
|
|
|
|
---------------- |
|
|
|
TOTAL NET EQUITY |
26.445.352,90 |
|
|
|
|
================ |
|
|
|
TOTAL LIABILITIES |
35.465.868,19 |
|
|
|
PROFIT AND LOSS ACCOUNTS AS OF 31/12/2008. |
|
( FIGURES ARE IN REAIS ). |
|
|
31/12/2008 |
|
|
|
|
|
|
|
|
GROSS SALES |
60.987.952,42 |
|
|
|
(-) TAXES ON SALES |
10.047.293,97 |
|
|
|
|
---------------- |
|
|
|
NET SALES |
50.940.658,45 |
|
|
|
(-) COST OF SOLD GOODS |
18.491.952,37 |
|
|
|
|
---------------- |
|
|
|
GROSS PROFIT |
32.448.706,08 |
|
|
|
OPERATING REVENUE (EXPENSE) |
-29.627.101,68 |
|
|
|
|
---------------- |
|
|
|
OPERATIONAL PROFIT (LOSS) |
2.821.604,40 |
|
|
|
CONTRIBUTION/INCOME TAX |
-1.056.660,89 |
|
|
|
|
---------------- |
|
|
|
NET PROFIT (LOSS) |
1.764.943,51 |
|
|
|
MONTHLY
SALES |
|||
|
|
2009 |
|
|
|
|
--------------------- |
|
|
|
JANUARY |
R$
4.016.634,94 |
|
|
|
FEBRUARY |
R$
4.003.498,11 |
|
|
|
MARCH |
R$
6.592.737,76 |
|
|
|
APRIL |
R$
5.030.023,34 |
|
|
|
MAY |
R$
5.536.543,56 |
|
|
|
JUNE |
R$
5.083.977,76 |
|
|
|
JULY |
R$
5.171.075,76 |
|
|
|
AUGUST |
R$
5.384.864,50 |
|
|
|
SEPTEMBER |
R$
5.993.066,18 |
|
|
|
OCTOBER |
|
|
|
|
NOVEMBER |
|
|
|
|
DECEMBER |
|
|
|
|
TOTAL |
R$
46.812.421,91 |
|
|
|
RATIOS: |
31/12/2008 |
|
|
|
QUICK RATIO |
1,09 |
|
|
|
|
|
|
CURRENT RATIO |
1,90 |
|
|
|
|
|
|
ACCOUNTS RECEIVABLE TURNOVER |
7,91 |
TIMES |
|
|
|
|
|
DAYS' SALES IN RECEIVABLES |
45,53 |
DAYS |
|
|
|
|
|
INVENTORY TURNOVER |
2,52 |
TIMES |
|
|
|
|
|
ACCOUNTS PAYABLE PERIOD |
33,09 |
DAYS |
|
|
|
|
|
RETURN ON ASSETS |
1,44 |
TIMES |
|
|
|
|
|
SALES TURNOVER ON NET EQUITY |
1,93 |
TIMES |
|
|
|
|
|
NET WORTH TIE-UP |
,05 |
|
|
|
|
|
|
INDEBTEDNESS |
,34 |
|
|
|
|
|
|
EQUITY RATIO |
74,57 |
% |
|
|
|
|
|
WORKING CAPITAL RATIO |
90,24 |
% |
|
|
|
|
|
GENERAL SOLVENCY |
3,93 |
|
|
|
|
|
|
RETURN ON NET EQUITY |
6,67 |
% |
|
|
|
|
|
RETURN ON SALES (PROFIT MARGIN) |
3,46 |
% |
|
|
|
|
|
GROSS PROFIT MARGIN |
63,70 |
% |
|
|
|
|
|
OPERATIONAL RESULT |
5,54 |
% |
|
|
|
|
|
SALES TURNOVER ON LIABILITIES |
5,65 |
TIMES |
|
|
|
|
|
FOREIGN CURRENCY ON ASSETS |
|
|
|
|
|
|
|
FOREIGN CURRENCY ON LIABILITIES |
|
|
|
|
|
|
|
EXCHANGE
RATE: |
|
|
US$ 1,00 = R$ 1,83 |
- OFFICIAL RATE ON
11/04/2012 |
|
US$ 1,00 = R$ 2,33 |
- OFFICIAL RATE ON
31/12/2008 |
|
COMMENTS
ON THE FINANCIAL INFORMATION: |
|
FOLLOWS ATTACHED WORKSHEET WITH MAIN FINANCIAL RATIOS. THE FIGURES AVAILABLE SHOW A GOOD FINANCIAL STANDING. IT
IS NOTED HIGH LIQUIDITY RATIOS AND IMPORTANT WORKING CAPITAL, LOW LEVEL OF
INDEBTEDNESS AS WELL AS GROWING SALES AND PROFITABLE RESULTS. |
|
REAL
ESTATE: |
NOT AVAILABLE
|
DETAIL
OF OWNED REAL ESTATE: |
|
TYPE: |
OTHERS |
|
VALUE: |
R$ ,00 |
|
REMARKS: |
THE PREMISES ARE OWNED. THE PREMISES COMPREHEND A PLANT A
LABORATORY AND RELATED FACILITIES. TOTAL BUILD AREA IS 10.000 M2. THE
ESTIMATE VALUE IS USD 5.000.000,00. |
|
VEHICLES: |
OWNED VEHICLES ARE
VALUED AT R$ 22.630,58
|
MACHINES: |
OWNED MACHINES AND
EQUIPMENTS ARE VALUED AT R$ 2.797.195,58
|
NOT AVAILABLE. |
|
|
BRANCH/PHONE: |
|
|
BANCO BRADESCO S/A |
11 4126-7000 |
|
|
BANCO DO BRASIL S/A |
11 4337-7373 |
|
|
BANCO MERCANTIL DE SÃO PAULO S/A |
11 5062-7811 |
|
|
REMARKS: IN BRAZIL THE BANKS ARE PROHIBITED BY LAW TO
PROVIDE INFORMATION OR ANY KIND OF COMMENTS ABOUT THEIR CLIENTS. DUE TO THIS LAW
PROHIBITION WE ARE UNABLE TO PROVIDE ANY BANKING DETAILS. ACCORDING TO THE CENTRAL BANK OF BRAZIL OFFICIAL REPORT,
THE COMPANY HAS NO RETURNED CHECKS UP TO DATE. (IN THE TERMS OF
"CIRCULAR 1682 BRAZILIAN CENTRAL BANK"). |
|
THE SUBJECT IS ENGAGED IN THE MANUFACTURE OF ALLOPATHIC
MEDICINES FOR HUMAN USE. |
|
IMPORT
AND EXPORT: |
IMPORTS
FROM:
|
INDIA, GERMANY, ITALY, SWITZERLAND, CHINA AND SPAIN. |
EXPORTS TO:
|
DOES NOT EXPORT. |
|
MAIN
CLIENTS: |
|
|
|
|
|
|
|
DOMESTIC
CLIENTS: |
|
|
|
NOT AVAILABLE. |
|
|
|
STAFF: |
|
|
|
THE COMPANY HAS: 348
EMPLOYEE(S) |
|
THE SUBJECT IS A WELL-ESTABLISHED COMPANY, OPERATING SINCE
1978. SO FAR IT HAS A CLEAR TRADE HISTORY AND NORMAL PAYMENT BEHAVIOR. THE COMPANY HAS TRADE RELATIONS WITH SEVERAL SUPPLIERS IN
BRAZIL. THE SUPPLIERS EXTEND CREDIT FACILITIES TO THE SUBJECT IN TERMS AND
AMOUNTS ACCORDING TO THE COMPANY'S NEEDS AND SO FAR NO PAYMENT PROBLEMS ARE
NOTED. |
|
MAIN
SUPPLIERS: |
|
|
|
|
|
|
|
DOMESTIC
SUPPLIERS: |
|
PHONE: |
|
ALLPLAS INDÚSTRIA E COM. PLAST. LTDA |
|
11 4612-2233 |
|
CHEMYNION QUIMICA LTDA |
|
11 2173-0109 |
|
MARCRON IND. GRAFICA LTDA |
|
11 4392-8156 |
|
PALMARES ERVY COM. IMPORTADORA LTDA |
|
11 4054-6400 |
|
PURIFARMA IND. COMERCIO LTDA |
|
11 2272-5600 |
|
ROSET ARTES GRÁFICAS E EDITORA LTDA |
|
11 5642-1944 |
|
VALDEQUIMICA PRODUTOS QUIMICOS LTDA |
|
11 3721-6407 |
|
VEDAT TAMPAS HERMÉTICAS LTDA |
|
11 494-4266 |
|
VITON BEM LTDA |
|
11 5641-8224 |
|
WHEATON DO BRASIL IND. E COMÉRCIO LTDA |
|
11 4351-4433 |
|
PAYMENT
HISTORY: |
|
2 SUPPLIERS REPORTED PAYMENTS: |
|
TOTAL
AMOUNT: R$ 6.307,00 |
|
|
|
AMOUNT OF INVOICES PAID: 2 |
|
TOTAL OF PROMPT PAYMENTS: 100% |
|
HIGHEST INVOICE: R$ 4.679,00 |
|
HIGHEST CREDIT: R$ 4.679,00 |
|
THE SUBJECT IS A WELL-ESTABLISHED COMPANY IN BUSINESS FOR
SEVERAL YEARS. UP TO DATE IT HAS A CLEAR TRADE HISTORY AND NORMAL PAYMENT PERFORMANCE. BASED ON THE GENERAL INFORMATION AVAILABLE IT IS BELIEVED
THAT GOOD TRADE RELATIONS MAY BE ESTABLISHED. CREDIT FACILITIES MAY BE
EXTENDED WITHIN TERMS AND AMOUNTS ADEQUATE TO THE COMPANY'S FINANCIAL
STRENGTH. DESPITE THE ABSENCE OF UPDATED FINANCIAL DATA A CREDIT
LIMIT OF USD 300.000,00 MAY BE CONSIDERED. |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.51.41 |
|
|
1 |
Rs.81.93 |
|
Euro |
1 |
Rs.67.66 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect.
Satisfactory capability for payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.